BACKGROUND: Pathogenesis of hepatitis C virus (HCV) associated liver injury is thought to be due to the host antiviral immune response. Using a quantitative, competitive RT-PCR technique, we recently showed that expression of interferon gamma (IFN-gamma) and IFN-gamma inducible type of nitric oxide synthase (iNOS) is increased in homogenised liver tissue of patients with chronic HCV infection. AIMS: To determine the cellular origin of IFN-gamma and iNOS expression and to examine the hypothesis that T cell derived IFN-gamma secretion induces iNOS in hepatocytes in chronic HCV infection. METHODS: By applying a non-radioactive in situ hybridisation method combined with indirect immunofluorescence, 33 liver biopsy specimens from patients with chronic HCV infection were studied for cellular expression of IFN-gamma and iNOS mRNA. RESULTS: In chronic HCV infection, both IFN-gamma and iNOS gene expression were significantly increased. IFN-gamma and iNOS mRNA were observed in CD3+ lymphocytes infiltrating portal tracts and hepatic lobules, but not in hepatocytes. CONCLUSIONS: Results are consistent with previous reports that IFN-gamma and iNOS transcripts are elevated in chronic HCV infection. In contrast to the hypothesis, IFN-gamma expressing T cells do not induce iNOS in hepatocytes, but probably in T cells. T lymphocytes expressing IFN-gamma and/or iNOS have the potential to participate in autocrine and paracrine pathways that may contribute to the pathobiology of chronic hepatitis C.
BACKGROUND: Pathogenesis of hepatitis C virus (HCV) associated liver injury is thought to be due to the host antiviral immune response. Using a quantitative, competitive RT-PCR technique, we recently showed that expression of interferon gamma (IFN-gamma) and IFN-gamma inducible type of nitric oxide synthase (iNOS) is increased in homogenised liver tissue of patients with chronic HCV infection. AIMS: To determine the cellular origin of IFN-gamma and iNOS expression and to examine the hypothesis that T cell derived IFN-gamma secretion induces iNOS in hepatocytes in chronic HCV infection. METHODS: By applying a non-radioactive in situ hybridisation method combined with indirect immunofluorescence, 33 liver biopsy specimens from patients with chronic HCV infection were studied for cellular expression of IFN-gamma and iNOS mRNA. RESULTS: In chronic HCV infection, both IFN-gamma and iNOS gene expression were significantly increased. IFN-gamma and iNOS mRNA were observed in CD3+ lymphocytes infiltrating portal tracts and hepatic lobules, but not in hepatocytes. CONCLUSIONS: Results are consistent with previous reports that IFN-gamma and iNOS transcripts are elevated in chronic HCV infection. In contrast to the hypothesis, IFN-gamma expressing T cells do not induce iNOS in hepatocytes, but probably in T cells. T lymphocytes expressing IFN-gamma and/or iNOS have the potential to participate in autocrine and paracrine pathways that may contribute to the pathobiology of chronic hepatitis C.
Authors: H J Radzun; M L Hansmann; H J Heidebrecht; S Bödewadt-Radzun; H H Wacker; H Kreipe; H Lumbeck; C Hernandez; C Kuhn; M R Parwaresch Journal: Lab Invest Date: 1991-09 Impact factor: 5.662
Authors: K Ando; L G Guidotti; S Wirth; T Ishikawa; G Missale; T Moriyama; R D Schreiber; H J Schlicht; S N Huang; F V Chisari Journal: J Immunol Date: 1994-04-01 Impact factor: 5.422
Authors: P L Majano; C García-Monzón; M López-Cabrera; E Lara-Pezzi; E Fernández-Ruiz; C García-Iglesias; M J Borque; R Moreno-Otero Journal: J Clin Invest Date: 1998-04-01 Impact factor: 14.808
Authors: T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura Journal: Proc Natl Acad Sci U S A Date: 1994-01-18 Impact factor: 11.205
Authors: M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner Journal: N Engl J Med Date: 1992-12-31 Impact factor: 91.245
Authors: R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman Journal: Hepatology Date: 1981 Sep-Oct Impact factor: 17.425
Authors: K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari Journal: J Exp Med Date: 1993-11-01 Impact factor: 14.307
Authors: Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski Journal: Proc Natl Acad Sci U S A Date: 2002-12-13 Impact factor: 11.205
Authors: Assem M El-Sherif; Mohamed A Abou-Shady; Ashraf M Al-Bahrawy; Reda M Bakr; Abdel-Moneim M Hosny Journal: Hepatol Int Date: 2008-04-22 Impact factor: 6.047
Authors: Keigo Machida; Kevin T-H Cheng; Vicky M-H Sung; Ki Jeong Lee; Alexandra M Levine; Michael M C Lai Journal: J Virol Date: 2004-08 Impact factor: 5.103